Table 2 Steroid hormone receptor expression in ovarian cancer: rate of expression of the indicated receptors
ERα | ERβ (nuclear) | ERβ (cytoplasmic) | PR | ||
|---|---|---|---|---|---|
All | All | 121/172 (70.35) | 79/167 (45.04) | 39/169 (23.08) | 55/165 (33.33) |
G2 | 33/47 (70.21) | 29/46 (63.04) | 12/46 (26.09) | 15/47 (31.91) | |
G3 | 78/111 (70.27) | 45/109 (41.28) | 19/109 (17.43) | 36/106 (33.96) | |
FIGO I + II | 21/32 (70.54) | 12/30 (40.00) | 7/31 (22.58) | 16/31 (51.61) | |
FIGO III + IV | 79/112 (65.63) | 45/100 (45.00) | 7/31 (22.58) | 31/108 (28.70) | |
Serous | Serous | 99/133 (74.44) | 59/131 (49.62) | 27/131 (20.61) | 46/128 (35.94) |
G2 | 23/31 (74.19) | 18/31 (58.06) | 9/31 (29.03) | 11/31 (35.48) | |
G3 | 71/97 (73.20) | 38/95 (40.00) | 17/95 (17.89) | 33/92 (35.87) | |
FIGO I + II | 15/20 (75.00) | 5/19 (26.32) | 6/20 (30.00) | 12/19 (63.16) | |
FIGO III + IV | 70/96 (72.92) | 45/95 (47.37) | 19/92 (20.65) | 28/92 (30.43) | |